Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006

被引:38
|
作者
Goldacre, Michael J. [1 ]
Duncan, Marie [1 ]
Griffith, Myfanwy [1 ]
Turner, Martin R. [2 ]
机构
[1] Univ Oxford, Dept Publ Hlth, Unit Health Care Epidemiol, Oxford OX3 7LF, England
[2] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England
关键词
Multiple sclerosis; Motor neuron disease; Parkinson's disease; Epilepsy; Mortality; Trends; MORTALITY-RATES; MORBIDITY;
D O I
10.1007/s00415-009-5392-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The objective of this study is to report trends in mortality, as certified on death certificates, from multiple sclerosis (MS), motor neuron disease (MND), primary Parkinson's disease (PD), and epilepsy, analysing not only the underlying cause of death but also all certified causes for each disease. Death records in the Oxford region, 1979-2006, and England, 1996-2006, were analysed for ascertaining the trends in mortality. The percentage of deaths coded as the underlying cause changed over time, coinciding with changes to the rules for selecting the underlying cause of death. Changes over time to coding rules had a large impact on apparent trends in death rates for PD when studied by underlying cause alone. They also had significant, though smaller, effects on trends in death rates for MS, MND and epilepsy. Nationally, in the last period of the study, underlying cause mortality identified 64% of deaths with a mention of MS, 88% of MND, 56% of PD, and 48% of epilepsy. In the longstanding Oxford data from 1979 to 2006, death rates based on all certified causes of death showed no significant change for MS; an upward trend for MND (notably in women over 75), though only in the last few years of the study; a significant but small decline for PD; and no significant change for epilepsy. When mortality statistics are analysed by underlying cause only, their value is reduced. A substantial percentage of neurological deaths are missed. Time trends may be misleading. All certified causes for each disease, as well as the underlying cause, should be analysed.
引用
收藏
页码:706 / 715
页数:10
相关论文
共 50 条
  • [31] Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson's Disease
    Frahm, Niklas
    Hecker, Michael
    Zettl, Uwe Klaus
    CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (38) : 4008 - 4016
  • [32] The Contribution of Small Vessel Disease to Neurodegeneration: Focus on Alzheimer's Disease, Parkinson's Disease and Multiple Sclerosis
    Paolini Paoletti, Federico
    Simoni, Simone
    Parnetti, Lucilla
    Gaetani, Lorenzo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [33] Natural products targeting cellular processes common in Parkinson's disease and multiple sclerosis
    Xu, Xuxu
    Han, Chaowei
    Wang, Pengcheng
    Zhou, Feimeng
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [34] Gut microbiome alpha-diversity is not a marker of Parkinson's disease and multiple sclerosis
    Plassais, Jonathan
    Gbikpi-Benissan, Guillaume
    Figarol, Marine
    Scheperjans, Filip
    Gorochov, Guy
    Derkinderen, Pascal
    Cervino, Alessandra C. L.
    BRAIN COMMUNICATIONS, 2021, 3 (02)
  • [35] Palliative and end-of-life care in advanced Parkinson's disease and multiple sclerosis
    Campbell, Colin W.
    Jones, Edward J. S.
    Merrills, Jane
    CLINICAL MEDICINE, 2010, 10 (03) : 290 - 292
  • [36] The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis
    Cochrane, Graham D.
    Rizvi, Syed
    Abrantes, Ana M.
    Crabtree, Brigid
    Cahill, Jonathan
    Friedman, Joseph H.
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (09) : 1093 - 1095
  • [37] Anomia in left hemisphere stroke, multiple sclerosis and Parkinson's disease - a comparative study
    Kristensson, Joana
    Longoni, Francesca
    Ostberg, Per
    Smith, Signe Rodseth
    Ake, Sabina
    Saldert, Charlotta
    DISABILITY AND REHABILITATION, 2024, 46 (11) : 2294 - 2316
  • [38] Progressive dopamine neuron loss in Parkinson's disease: The multiple hit hypothesis
    Carvey, Paul M.
    Punati, Ashok
    Newman, Mary B.
    CELL TRANSPLANTATION, 2006, 15 (03) : 239 - 250
  • [39] Unexpected aggravation of Parkinson's disease by a mesencephalic multiple sclerosis lesion
    Kreisler, A
    Stankoff, B
    Ribeiro, MJ
    Agid, Y
    Lubetzki, C
    Fontaine, B
    JOURNAL OF NEUROLOGY, 2004, 251 (12) : 1526 - 1527
  • [40] Car accidents in drivers with Parkinson's disease or multiple sclerosis: A Swedish nationwide study
    Anjemark, Linnea
    Selander, Helena
    Persson, Hanna C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (06) : 1631 - 1638